Endocrine therapy is one of the major treatments of breast cancer and continues to be the cornerstone of treatment for estrogen receptor-positive (ER+) breast cancer due to its effectiveness and favorable toxicity profile [1]. The gene discussed is ESR1; the disease is breast carcinoma.